targazyme.comBioTechFounded: 2005Funding to Date: $2.5MM
Targazyme is a clinical-stage biopharmaceutical company developing novel enzyme-based platform technologies and products to improve clinical efficacy and cost of care outcomes for cell therapy, immunotherapies for autoimmune diseases and cancer, stem cell transplantation, gene therapy and regenerative medicine.
Forge and SharesPost have teamed up to provide you with an enhanced trading experience.
